Glycolic Acid During Pregnancy & Breastfeeding: What's Safe?

Most dermatologists consider low-concentration topical glycolic acid (10% or below) low-risk during pregnancy and breastfeeding, while professional-strength peels should wait until after delivery [1]. That guidance comes with an important caveat: no controlled human studies have evaluated topical glycolic acid's effects on fetal development, so it rests on pharmacokinetic reasoning, limited animal data, and expert clinical consensus. The question matters because pregnancy changes skin dramatically - hormonal surges can trigger acne, melasma, and hyperpigmentation, the very concerns glycolic acid is most effective at treating.

Why This Question Matters

Pregnancy-related skin changes affect up to 90% of pregnant individuals [2]. The most common concerns include:

• Melasma (the "mask of pregnancy") - hormone-driven dark patches on the cheeks, forehead, and upper lip, affecting 50%–70% of pregnant individuals [3]
• Pregnancy acne - hormonal fluctuations, particularly increased androgens in the first trimester, can trigger or worsen acne
• Hyperpigmentation - linea nigra, darkening of areolae, and general uneven skin tone
• Increased oil production - progesterone stimulates sebaceous glands

These are exactly the conditions glycolic acid treats well. But pregnancy also dramatically raises the stakes: any substance applied to the skin has the theoretical potential to be absorbed systemically and reach the developing fetus. For most skincare ingredients, this concern is theoretical rather than demonstrated - but the absence of proof of harm is not the same as proof of safety. This distinction matters profoundly for YMYL decisions during pregnancy.

FDA Classification and Regulatory Context

Cosmetics vs. Drugs: A Critical Distinction

Glycolic acid in skincare products is classified as a cosmetic ingredient by the U.S. Food and Drug Administration - not a drug. This distinction has significant regulatory consequences. Cosmetic ingredients do not undergo the same premarket safety testing, clinical trials, or pregnancy classification that FDA-regulated drugs require [4].

This means glycolic acid has never been assigned an FDA pregnancy risk category in the way that prescription drugs are. When you see discussions about "Category A" through "Category X" for medications, these do not apply to cosmetic ingredients like glycolic acid.

The Old FDA Pregnancy Categories (A/B/C/D/X)

For decades, the FDA classified prescription drugs into five pregnancy risk categories:

• Category A: Adequate human studies show no fetal risk
• Category B: Animal studies show no risk; no adequate human studies (or animal studies showed risk but human studies did not)
• Category C: Animal studies show adverse effects; no adequate human studies. Use only if benefit justifies risk
• Category D: Evidence of human fetal risk, but benefits may outweigh risk in serious conditions
• Category X: Proven fetal abnormalities. Contraindicated in pregnancy

These categories were retired in 2015 and replaced by the Pregnancy and Lactation Labeling Rule (PLLR), which requires narrative descriptions of available data rather than a single letter grade [5]. The old categories, while still widely referenced, were always limited - they oversimplified complex risk-benefit profiles.

Why This Matters for Glycolic Acid

Because glycolic acid is a cosmetic ingredient, it was never evaluated under either the old category system or the new PLLR framework. There is no official FDA pregnancy classification for topical glycolic acid. This is a gap in the regulatory landscape, not a safety endorsement or a condemnation. It simply means the burden of evaluating risk falls on individual clinicians and their patients, informed by whatever evidence is available.

What the Research Shows

Systemic Absorption: The Central Question

The safety of any topical ingredient during pregnancy hinges on one question: how much gets into the bloodstream and potentially reaches the fetus? For glycolic acid, the pharmacokinetic evidence is reassuring.

Glycolic acid has a molecular weight of 76 daltons - small enough to penetrate the stratum corneum (the outermost layer of dead skin cells) effectively. This is what makes it a good exfoliant. However, penetration past the epidermis into the dermis and beyond is limited by several factors [6]:

• pH-dependent ionization: At the pH of most skincare products (3.5–4.5), a significant fraction of glycolic acid is ionized. Ionized molecules penetrate skin poorly.
• Small application area: A thin layer applied to the face covers roughly 600 cm2 - a small fraction of total body surface area.
• Short contact time: Leave-on products are applied in thin layers; the amount of acid that can absorb before being diluted by the skin's own moisture and buffering is limited.
• Rapid metabolism: Glycolic acid that does reach the bloodstream is quickly metabolized to glyoxylic acid and then to glycine (a common amino acid) or oxalic acid, and is excreted by the kidneys [7].

Bozzo et al. (2011), in a review of skin care product safety during pregnancy published in the Canadian Family Physician, concluded that topical glycolic acid products are expected to have minimal systemic absorption and are not anticipated to pose a risk during pregnancy based on pharmacokinetic reasoning [1].

Low-Concentration Products (2%–10%) vs. Professional Peels (20%–70%)

The risk profile differs significantly between OTC and professional concentrations:

Over-the-counter products (2%–10%):

• Applied as thin layers to a limited area (usually just the face)
• Buffered to pH 3.5–4.5 in most formulations
• Minimal penetration beyond the epidermis
• Negligible systemic absorption expected

Professional chemical peels (20%–70%):

• Applied at much higher concentrations, often at lower pH (2.0–3.0)
• Greater penetration depth - medium-depth peels intentionally reach into the dermis
• Larger surface area may be treated (face, neck, chest)
• Theoretically greater systemic absorption, though still not well-quantified
• More significant inflammatory response, which could independently affect pregnancy outcomes

This concentration distinction is critical. The risk assessment for a 5% glycolic acid toner used nightly is fundamentally different from a 50% professional peel administered in a clinical setting.

Animal Studies

Animal reproductive toxicology data on glycolic acid is limited. The Cosmetic Ingredient Review (CIR) Expert Panel's safety assessment found that orally administered glycolic acid caused developmental toxicity in rats only at high doses that also made the mothers sick - doses far beyond anything achievable through topical cosmetic use. The panel concluded that glycolic acid is safe in cosmetics at concentrations of 10% or below with a formulation pH of 3.5 or above [8]. No large-scale animal reproductive toxicology studies equivalent to those required for pharmaceutical drugs have been conducted specifically for topical glycolic acid.

Human Studies

No controlled human trials have evaluated the effects of topical glycolic acid on pregnancy outcomes, fetal development, or breast milk composition. This is a significant evidence gap, but it is not unusual - the vast majority of cosmetic ingredients lack pregnancy-specific human data, because clinical trials in pregnant populations carry ethical and legal barriers that make them rare for any non-essential intervention [1].

Dermatologist Consensus

Despite the absence of definitive clinical data, a practical consensus has emerged among dermatologists and obstetricians. Murase et al. (2014), in a comprehensive review of dermatological conditions during pregnancy published in the Journal of the American Academy of Dermatology, provided guidance on managing common skin conditions without exposing the fetus to unnecessary risk [3].

Generally Considered Low-Risk

• Low-concentration glycolic acid (10% or below) in leave-on products (toners, serums, moisturizers) is considered low-risk by most dermatologists due to minimal systemic absorption [1]
• Lactic acid at low concentrations - the reasoning is the same as for glycolic acid, and lactic acid is also a natural component of the skin's own moisturizing system [6]
• Azelaic acid - this is one of the best-studied topical ingredients during pregnancy. It is FDA Category B (animal studies show no risk, limited human data available) and is commonly prescribed for acne during pregnancy [9]; many dermatologists also reach for it to manage melasma and hyperpigmentation

Generally Recommended to Avoid

• Professional glycolic acid peels (20%+) - the deeper penetration and higher concentrations create a larger theoretical risk. Most dermatologists advise postponing professional chemical peels until after pregnancy and breastfeeding [3]
• Retinoids (Category X) - oral isotretinoin is a known teratogen causing severe birth defects. Topical retinoids (tretinoin, adapalene, tazarotene) are also avoided as a precaution, though topical systemic absorption is very low. The retinoid class is the clearest example of a skincare ingredient contraindicated in pregnancy [3]
• Hydroquinone - used for hyperpigmentation, hydroquinone has relatively high systemic absorption (an estimated 35%–45% is absorbed through the skin). Most experts recommend minimizing or avoiding it during pregnancy until further safety data exists [1]
• High-dose salicylic acid (>2%) - low-dose topical salicylic acid (2% or below) is generally considered low-risk, but high-dose salicylic acid peels and oral salicylates are avoided due to the known risks of aspirin (a salicylate) in pregnancy [1]

Safe Alternatives During Pregnancy

If you and your healthcare provider decide to avoid glycolic acid during pregnancy, or if you simply want to err on the side of caution, effective alternatives exist.

For those looking for a gentler AHA alternative, lactic acid offers similar exfoliating benefits with a larger molecular weight (90 Da vs. glycolic acid's 76 Da), meaning shallower penetration and generally less irritation. It also functions as a humectant, providing hydration alongside exfoliation.

Breastfeeding Considerations

Even less clinical data exists for glycolic acid use during breastfeeding than during pregnancy. However, the pharmacokinetic reasoning is, if anything, more reassuring.

The Exposure Pathway

For a topical skincare ingredient to affect a breastfed infant, it must:

1. Be absorbed through the mother's skin into the bloodstream (minimal for glycolic acid at OTC concentrations)
2. Reach sufficient plasma concentration to distribute into breast milk (glycolic acid is rapidly metabolized)
3. Be present in breast milk at a concentration high enough to affect the infant (no data suggests this occurs)
4. Be absorbed by the infant's gastrointestinal tract in a bioactive form

Each step in this pathway reduces the exposure by orders of magnitude. For a small, rapidly metabolized, water-soluble molecule like glycolic acid applied topically to the face, the amount that would theoretically reach breast milk is negligible [1] [10].

What Experts Say

The LactMed database, maintained by the National Library of Medicine and considered the authoritative reference for drug safety during lactation, has an entry for glycolic acid. It concludes that topical glycolic acid is unlikely to be appreciably absorbed or to appear in breast milk, and is therefore considered safe to use while breastfeeding. The entry's one caution is to avoid applying it to areas where an infant could have direct skin or oral contact [10].

Most dermatologists apply the same guidance during breastfeeding as during pregnancy: low-concentration topical products (10% or below) are considered low-risk, while professional-strength peels should be deferred. Some practitioners are slightly more permissive during breastfeeding than during pregnancy, reasoning that the fetal exposure pathway (direct placental transfer) is more efficient than the breast milk pathway (multiple dilution steps) [3].

Practical Recommendations

If you are pregnant, planning to become pregnant, or breastfeeding, here is a step-by-step approach to glycolic acid use:

Step 1: Talk to Your Healthcare Provider

This is not a formality. Your OB-GYN or midwife knows your specific health history, pregnancy risk factors, and can provide personalized guidance. Bring a list of your current skincare products - including concentrations and active ingredients - to your next prenatal appointment.

Step 2: Evaluate Your Current Products

Review each product in your routine. Identify:

• Any product containing retinoids (retinol, retinaldehyde, tretinoin, adapalene, tazarotene) - these should be discontinued immediately
• Any product containing hydroquinone - discontinue
• Glycolic acid products - note the concentration. If it is 10% or below, discuss with your provider. If it is above 10%, discontinue or switch to a lower concentration
• Check our interaction checker to evaluate your full routine

Step 3: If Continuing Glycolic Acid

If you and your provider decide that continuing low-concentration glycolic acid is appropriate:

• Keep concentrations at 10% or below - this is the range where systemic absorption is negligible
• Use leave-on products, not peels - even at-home peels at 15%–20% should be avoided
• Apply to the face only - minimize the treated surface area
• Maintain sun protection - glycolic acid increases UV sensitivity (see our safety guide), and pregnancy hormones independently increase melanin production. SPF 30+ broad-spectrum sunscreen is essential to prevent worsening melasma
• Monitor for increased sensitivity - pregnancy changes skin reactivity. A product that was well-tolerated before pregnancy may cause irritation during pregnancy. If you notice increased redness, stinging, or dryness, reduce frequency or stop

Step 4: If Avoiding Glycolic Acid

If you prefer to stop glycolic acid entirely, replace it with:

• Azelaic acid (15%–20%) for acne [9] - dermatologists also commonly turn to it for hyperpigmentation during pregnancy
• Low-concentration lactic acid for gentle exfoliation - see our glycolic vs. lactic acid comparison for how these two AHAs differ
• Vitamin C serum for brightening and antioxidant protection
• A consistent sunscreen habit - arguably the single most effective intervention for preventing pregnancy-related melasma

Step 5: After Pregnancy and Breastfeeding

Once you are no longer pregnant or breastfeeding, you can resume your full skincare routine, including professional-strength treatments if desired. If you stopped glycolic acid during pregnancy, reintroduce it gradually - your skin's tolerance may have changed. Start with the lower end of your previous concentration and rebuild tolerance over 2–4 weeks. For a structured reintroduction approach, see our guide on how to use glycolic acid.

Ingredients That Are Clearly Contraindicated

For context, it helps to understand which ingredients have strong evidence of pregnancy risk - in contrast to glycolic acid's uncertain but likely low-risk profile.

Oral isotretinoin (Accutane) is the most well-established teratogen in dermatology. It causes severe birth defects in a high percentage of exposed pregnancies, including craniofacial, cardiac, and central nervous system malformations [3]. It requires the iPLEDGE program with mandatory pregnancy testing and two forms of contraception [11].

Topical retinoids (tretinoin, adapalene, tazarotene) have not been definitively linked to birth defects in human studies, but case reports exist, and the retinoid class mechanism of action (affecting cell differentiation and development) provides strong biological plausibility for fetal risk. They are avoided as a precaution [3].

Hydroquinone has an estimated 35%–45% systemic absorption through the skin - dramatically higher than glycolic acid. While available data have not linked it to major malformations, the high absorption rate combined with limited safety data leads most practitioners to recommend minimizing exposure [1].

This context is important: glycolic acid's safety profile during pregnancy, while not fully characterized, is substantially more reassuring than these clearly problematic ingredients. The minimal systemic absorption of topical glycolic acid at OTC concentrations is the key differentiating factor.

Frequently Asked Questions

Can I use glycolic acid face wash while pregnant?

A glycolic acid face wash is a rinse-off product with very brief skin contact time (typically 30–60 seconds). The combination of short contact time and rinsing means even less absorption than a leave-on product. Most dermatologists consider glycolic acid face washes to be among the lowest-risk glycolic acid products during pregnancy. However, discuss with your provider, as individual circumstances vary.

Is glycolic acid safer than salicylic acid during pregnancy?

These are different concerns. Low-dose topical salicylic acid (2% or below) is generally considered low-risk during pregnancy, similar to low-concentration glycolic acid. The concern with salicylic acid is its relationship to aspirin (acetylsalicylic acid) - oral salicylates are associated with pregnancy complications. But topical application at low concentrations produces minimal systemic absorption for both ingredients [1]. For general side effect profiles, see our side effects overview.

Should I stop glycolic acid when trying to conceive?

Most dermatologists do not recommend stopping low-concentration topical glycolic acid while trying to conceive. The concern about fetal exposure is most relevant during the first trimester, when organogenesis (organ formation) occurs. By the time most people confirm pregnancy (4–6 weeks), a brief period of continued glycolic acid use at low concentrations is not considered a significant risk given the minimal systemic absorption. However, if you prefer to be cautious, switching to azelaic acid before conception is a reasonable approach.

Can glycolic acid cause miscarriage?

There is no evidence - from human studies, animal studies, or case reports - linking topical glycolic acid use to miscarriage. Given the negligible systemic absorption of topical glycolic acid at consumer concentrations, a causal relationship would be biologically implausible. If you have concerns about miscarriage risk from any skincare product, discuss them with your obstetrician.

What about glycolic acid body lotions during pregnancy?

Body lotions cover a much larger surface area than facial products, which theoretically increases total absorption. While the concentration in body lotions is typically low (5%–10%), the increased surface area is a consideration. Some dermatologists recommend limiting glycolic acid to facial application during pregnancy and using physical exfoliation methods (washcloths, gentle scrubs) on the body instead. Discuss your specific products and concerns with your provider.

References

1. 1. Bozzo P, Chua-Gocheco A, Einarson A. (2011). Safety of skin care products during pregnancy. Can Fam Physician. LinkReview
2. 2. Soma-Pillay P, Nelson-Piercy C, Tolppanen H, Mebazaa A. (2016). Physiological changes in pregnancy. Cardiovasc J Afr. doi:10.5830/CVJA-2016-021Review
3. 3. Murase JE, Heller MM, Butler DC. (2014). Safety of dermatologic medications in pregnancy and lactation: Part I. Pregnancy. J Am Acad Dermatol. doi:10.1016/j.jaad.2013.09.010Review
4. 4. U.S. Food and Drug Administration. (2023). FDA Authority Over Cosmetics: How Cosmetics Are Not FDA-Approved, but Are FDA-Regulated. FDA.gov. LinkRegulatory guidance
5. 5. U.S. Food and Drug Administration. (2014). Pregnancy and Lactation Labeling (Drugs) Final Rule. Federal Register. LinkRegulatory guidance
6. 6. Tang SC, Yang JH. (2018). Dual Effects of Alpha-Hydroxy Acids on the Skin. Molecules. doi:10.3390/molecules23040863Review
7. 7. Green BA, Yu RJ, Van Scott EJ. (2009). Clinical and cosmeceutical uses of hydroxyacids. Clin Dermatol. doi:10.1016/j.clindermatol.2009.06.023Review
8. 8. Andersen FA. (1998). Final Report on the Safety Assessment of Glycolic Acid, Ammonium, Calcium, Potassium, and Sodium Glycolates, and related compounds. Int J Toxicol. doi:10.1177/109158189801700101Safety assessment
9. 9. Meredith FM, Ormerod AD. (2013). The management of acne vulgaris in pregnancy. Am J Clin Dermatol. doi:10.1007/s40257-013-0041-9Review
10. 10. National Institute of Child Health and Human Development. (2021). Drugs and Lactation Database (LactMed): Glycolic Acid. National Library of Medicine. LinkDatabase entry
11. 11. U.S. Food and Drug Administration. (2024). Questions and Answers on the iPLEDGE REMS. FDA.gov. LinkRegulatory guidance

Related Articles

science14 min min read

Safety Profile & Drug Interactions

Clinical safety data for glycolic acid: contraindications, interactions, and CIR limits

fundamentals10 min min read

Glycolic Acid Side Effects and Safety

Common side effects, what's normal vs. concerning, and how to minimize risks

comparisons12 min min read

Glycolic Acid vs Lactic Acid

Compare glycolic acid and lactic acid - lactic acid is a gentler AHA alternative during pregnancy

tools5 min min read

Interaction Checker

Check which skincare ingredients are safe to combine with glycolic acid